Published in J Chromatogr on January 11, 1977
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
The C. elegans unc-104 gene encodes a putative kinesin heavy chain-like protein. Neuron (1991) 2.52
A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Nature (1987) 2.11
PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med (1984) 2.09
Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat Biotechnol (1998) 1.92
IGPHARM: interactive graphic package for pharmacokinetic analysis. Comput Biomed Res (1978) 1.71
Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol (1975) 1.63
Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes. Nature (1986) 1.62
Evidence for the release of endogenous substance P from intestinal nerves. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.61
An ankyrin-related gene (unc-44) is necessary for proper axonal guidance in Caenorhabditis elegans. J Cell Biol (1995) 1.55
A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J Biopharm Stat (1995) 1.54
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A (2000) 1.53
IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J Immunol (1999) 1.51
Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology (2003) 1.48
Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur J Pharmacol (1970) 1.47
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A (2005) 1.45
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des (2008) 1.43
Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression. Clin Pharmacol Ther (2012) 1.41
Zolpidem side-effects. Lancet (1993) 1.37
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
Cervical vagal schwannoma. A case report. Acta Otorhinolaryngol Ital (2009) 1.33
Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med (1979) 1.30
Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent. J Chromatogr (1979) 1.30
Gas chromatographic method for the determination of nomifensine in human plasma. J Chromatogr (1976) 1.29
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet (1981) 1.29
Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med (2000) 1.26
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets (2010) 1.25
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Polypeptide hormone regulation of gene expression. Thyrotropin-releasing hormone rapidly stimulates both transcription of the prolactin gene and the phosphorylation of a specific nuclear protein. J Biol Chem (1983) 1.24
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23
Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest (1995) 1.22
Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol (1972) 1.18
Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem (2001) 1.17
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann N Y Acad Sci (1971) 1.16
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Influence of age on mianserin pharmacokinetics. Psychopharmacology (Berl) (1982) 1.13
Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol (1978) 1.13
Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol (1979) 1.12
The structural origin of nonplanar heme distortions in tetraheme ferricytochromes c3. Biochemistry (1998) 1.12
Pharmacokinetics of nomifensine in man. Psychopharmacologia (1975) 1.12
Distribution of enteric neurons showing immunoreactivity for substance P in the guinea-pig ileum. Neuroscience (1980) 1.10
Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J Cell Sci (1999) 1.10
Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis. Allergy (2008) 1.09
Inter-observer and intra-observer variability of mammogram interpretation: a field study. Eur J Cancer (1992) 1.09
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep (2010) 1.09
Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer (2005) 1.07
Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol (1995) 1.07
Use of implicit methods from general sensitivity theory to develop a systematic approach to metabolic control. II. Complex systems. Math Biosci (1989) 1.07
Clincial pharmacokinetics in neonates. Clin Pharmacokinet (1976) 1.07
Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep (1997) 1.06
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol (2001) 1.05
Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett (1996) 1.04
Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol (2001) 1.04
The requirements of a specialist Breast Centre. Eur J Cancer (2013) 1.04
Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry (2011) 1.04
Osteogenic potential of mandibular vs. long-bone marrow stromal cells. J Dent Res (2010) 1.02
Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem (1998) 1.02
Monosodium glutamate and the Chinese restaurant syndrome. Nature (1970) 1.02
Use of implicit methods from general sensitivity theory to develop a systematic approach to metabolic control. I. Unbranched pathways. Math Biosci (1989) 1.02
Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids. J Chromatogr (1977) 1.01
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Br J Clin Pharmacol (1976) 1.01
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Evidence that axons containing substance P in the guinea-pig ileum are of intrinsic origin. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.01
A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol (2001) 1.00
Studies with biotinylated RBC: (1) use of flow cytometry to determine posttransfusion survival and (2) isolation using streptavidin conjugated magnetic beads. Adv Exp Med Biol (1992) 1.00
Basic metabolites of trazodone in humans. Arzneimittelforschung (1974) 1.00
Immunological identification of A1 adenosine receptors in brain cortex. J Neurosci Res (1995) 1.00
Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells. J Virol (1997) 0.99
The T cell receptor associated CD3-epsilon protein is phosphorylated upon T cell activation in the two tyrosine residues of a conserved signal transduction motif. Eur J Immunol (1993) 0.99
Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr (1978) 0.99
The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane. Mol Cell Biol (2000) 0.99
A computer program for enzyme kinetics that combines model discrimination, parameter refinement and sequential experimental design. Biochem J (1986) 0.98
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography. Cancer Treat Rep (1976) 0.98
Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol Pharmacol (1997) 0.97
Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry (1977) 0.97
Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun (1974) 0.97
Enzyme kinetic studies from progress curves. Biochem J (1986) 0.97
Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr Med Chem (2013) 0.96
Adaptive-optimal design in PET occupancy studies. Clin Pharmacol Ther (2010) 0.96
A program for the numerical integration of enzyme kinetic equations using small computers. Int J Biomed Comput (1985) 0.96
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease. Br J Pharmacol (2011) 0.96
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia (1975) 0.95
Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep (2013) 0.95
EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl) (1994) 0.95
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm (Vienna) (2006) 0.95
Inter-observer variability in the interpretation of mammograms. Tumori (1988) 0.95
Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. Br J Clin Pharmacol (1980) 0.94
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase. Br J Cancer (2010) 0.94